Mandatory product listing for dietary supplements is needed to improve US regulators’ oversight of the industry, says the Council for Responsible Nutrition.
However, imposing an MPL requirement for vitamin, mineral and supplement products as stated in provisions within legislation to re-authorize the Food and Drug Administration’s user fee programs for drugs, biologics and medical device applications isn’t urgent enough
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?